ID: ALA2316683

Max Phase: Preclinical

Molecular Formula: C43H61N3O11

Molecular Weight: 795.97

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)/C(=N\OC/C=C/c2cnc3ccccc3c2)[C@H](C)[C@H]2OC(=O)O[C@@]21C

Standard InChI:  InChI=1S/C43H61N3O11/c1-12-33-43(8)38(56-41(50)57-43)26(4)34(45-52-19-15-16-29-21-30-17-13-14-18-31(30)44-23-29)24(2)22-42(7,51-11)37(27(5)35(47)28(6)39(49)54-33)55-40-36(48)32(46(9)10)20-25(3)53-40/h13-18,21,23-28,32-33,36-38,40,48H,12,19-20,22H2,1-11H3/b16-15+,45-34+/t24-,25-,26+,27+,28-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1

Standard InChI Key:  GPMSCAIHDUSNFA-JFJRPKKDSA-N

Associated Targets(non-human)

Staphylococcus hominis 482 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus epidermidis 22802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus haemolyticus 1695 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus pyogenes 16140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus dysgalactiae 89 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus pneumoniae 31063 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Moraxella catarrhalis 3334 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Haemophilus influenzae 8812 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 795.97Molecular Weight (Monoisotopic): 795.4306AlogP: 5.97#Rotatable Bonds: 9
Polar Surface Area: 164.54Molecular Species: NEUTRALHBA: 14HBD: 1
#RO5 Violations: 3HBA (Lipinski): 14HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.93CX Basic pKa: 8.27CX LogP: 7.03CX LogD: 6.42
Aromatic Rings: 2Heavy Atoms: 57QED Weighted: 0.14Np Likeness Score: 1.02

References

1. Liang JH, An K, Lv W, Cushman M, Wang H, Xu YC..  (2013)  Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides.,  59  [PMID:23202851] [10.1016/j.ejmech.2012.10.054]
2. Liang JH, Lv W, Li XL, An K, Cushman M, Wang H, Xu YC..  (2013)  Synthesis and antibacterial activity of 9-oxime ether non-ketolides, and novel binding mode of alkylides with bacterial rRNA.,  23  (5): [PMID:23375796] [10.1016/j.bmcl.2012.12.070]
3. Han X, Lv W, Guo SY, Cushman M, Liang JH..  (2015)  Synthesis and structure-activity relationships of novel 9-oxime acylides with improved bactericidal activity.,  23  (19): [PMID:26349628] [10.1016/j.bmc.2015.08.020]
4. Tian JC, Han X, Lv W, Li YX, Wang H, Fan BZ, Cushman M, Liang JH..  (2017)  Design, synthesis and structure-bactericidal activity relationships of novel 9-oxime ketolides and reductive epimers of acylides.,  27  (7): [PMID:28256375] [10.1016/j.bmcl.2017.02.041]

Source